Thomas Hundsberger
6PUBLICATIONS
13CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Feb 25, 2025
First Single-Centre Experience with the Novel HIF-α Inhibitor Belzutifan in Switzerland.Tobias Peres, Stefanie Aeppli, Stefanie Fischer
|Jun 14, 2024
Start, switch and stop (triple-S) criteria for enzyme replacement therapy of late-onset Pompe disease: European Pompe Consortium recommendation update 2024.Benedikt Schoser, Nadine A M E van der Beek, Alexander Broomfield
|Apr 29, 2022
Next generation sequencing in adult patients with glioblastoma in Switzerland: a multi-centre decision analysis.A M Zeitlberger, P M Putora, S Hofer
|Nov 15, 2021
Assessment of neurological function using the National Institute of Health Stroke Scale in patients with gliomas.Anna Maria Zeitlberger, Marie-Claire Flynn, Monika Hollenstein
|Sep 24, 2020
MRI and 18FET-PET Predict Survival Benefit from Bevacizumab Plus Radiotherapy in Patients with Isocitrate Dehydrogenase Wild-type Glioblastoma: Results from the Randomized ARTE Trial.Hans-Georg Wirsching, Ulrich Roelcke, Jonathan Weller
|May 20, 2019
Comparison of recent pivotal recommendations for the diagnosis and treatment of late-onset Pompe disease using diagnostic nodes-the Pompe disease burden scale.Thomas Hundsberger, Benedikt Schoser, Daniela Leupold
Pageof 1
Frequent Collaborators
1 joint publications
Benedikt Schoser
1 joint publications
Nadine A M E van der Beek
1 joint publications
Jordi Diaz-Manera
1 joint publications
Cornelia Kornblum
1 joint publications
Pascal Laforet
1 joint publications
W W M Pim Pijnappel
1 joint publications
Thomas Scherer
1 joint publications
John Vissing
1 joint publications
Pieter A van Doorn
1 joint publications
Stephan Wenninger
